Received Nov 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
102 fever; awful chills; body aches; weak for 2 days after; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Flu unspecified (Flu vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine and Flu vaccine. On an unknown date, less than a day after receiving Shingles vaccine and Flu vaccine, the patient experienced fever (Verbatim: 102 fever), chills (Verbatim: awful chills), general body pain (Verbatim: body aches) and weakness (Verbatim: weak for 2 days after). The outcome of the fever, chills and general body pain were resolved (duration 24 hrs) and the outcome of the weakness was resolved (duration 2 days). It was unknown if the reporter considered the fever, chills, general body pain and weakness to be related to Shingles vaccine and Flu vaccine. It was unknown if the company considered the fever, chills, general body pain and weakness to be related to Shingles vaccine and Flu vaccine. Additional Information: GSK Receipt Date: 11-NOV-2025 This case was reported by a patient via interactive digital media. The follow-up could not be possible as no contact details were available. Patient got the first shingles vaccine along with the flu vaccine at the same time. Patient reported that he/she will not get the second shingles dose. The batch number was not provided, and we are unable to contact the reporter.